BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22298244)

  • 1. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.
    Rios DR; Carvalho MG; Figueiredo RC; Ferreira CN; Rodrigues VL; Souza RA; e Silva AC; Fernandes AP; Gomes KB; Dusse LM
    J Thromb Thrombolysis; 2012 Jul; 34(1):73-8. PubMed ID: 22298244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
    Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
    J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand Factor and a Disintegrin and Metalloproteinase with Eight Thrombospondin-type 1 Motif Levels in Hemodialysis Patients: Relation to Vascular Access Thrombosis.
    Elzorkany KMA; Montaser BAM; El-Hefnawy SM
    Indian J Nephrol; 2018; 28(4):278-282. PubMed ID: 30158745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
    De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
    Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
    Cohen-Hagai K; Rashid G; Einbinder Y; Ohana M; Benchetrit S; Zitman-Gal T
    Ann Lab Med; 2017 Mar; 37(2):155-158. PubMed ID: 28029003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
    Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
    Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.
    Chion CK; Doggen CJ; Crawley JT; Lane DA; Rosendaal FR
    Blood; 2007 Mar; 109(5):1998-2000. PubMed ID: 17053057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
    Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
    Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).
    Kobayashi T; Wada H; Nishioka N; Yamamoto M; Matsumoto T; Tamaru T; Nomura S; Masuya M; Mori Y; Nakatani K; Nishikawa M; Katayama N; Nobori T
    Thromb Res; 2008; 121(6):849-54. PubMed ID: 17900666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
    Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
    Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13.
    Hugenholtz GC; Ruitenbeek K; Adelmeijer J; Pereboom IT; Meijers JC; van der Bij W; Porte RJ; Erasmus ME; Lisman T
    Am J Transplant; 2015 Jul; 15(7):1958-66. PubMed ID: 25846964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    van den Born BJ; van der Hoeven NV; Groot E; Lenting PJ; Meijers JC; Levi M; van Montfrans GA
    Hypertension; 2008 Apr; 51(4):862-6. PubMed ID: 18332284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
    Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
    Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.